Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: J Clin Psychiatry. 2014 Oct;75(10):1040–1046. doi: 10.4088/JCP.13m08797

Table 1.

Characteristics of randomized subjects in two fluoxetine-discontinuation studies.

Study 1 Study 2
Characteristic Fluoxetine (N=299) Placebo (N=96) Fluoxetine (N=134) Placebo (N=135)
Age 39.6 ± 10.2 40.0 ± 10.5 39.8 ± 11.3 38.5 ± 11.1
% Male 34.4 20.8 50.0 31.7
Baseline mHAM-D 20.7 ± 3.5 21.5 ± 3.7 17.7 ± 5.1 17.2 ± 4.5
mHAM-D at randomization 2.9 ± 2.2 2.7 ± 2.3 4.8 ± 3.0 5.3 ± 3.5

Note: Age and gender data were only available for a subset of subjects in Study 2, N=82 in each group. mHAM-D data reflect the entire randomized sample.